Tyra Biosciences (TYRA)
(Delayed Data from NSDQ)
$22.04 USD
+0.46 (2.13%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $22.05 +0.01 (0.05%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth A Momentum C VGM
Tyra Biosciences, Inc. (TYRA) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$27.67 | $33.00 | $22.00 | 28.22% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Tyra Biosciences, Inc. comes to $27.67. The forecasts range from a low of $22.00 to a high of $33.00. The average price target represents an increase of 28.22% from the last closing price of $21.58.
Analyst Price Targets (6 )
Broker Rating
Tyra Biosciences, Inc. currently has an average brokerage recommendation (ABR) of 1.29 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.29 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, six are Strong Buy, representing 85.71% of all recommendations. A month ago, Strong Buy represented 85.71%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.29 | 1.29 | 1.29 | 1.33 | 1.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/15/2024 | Piper Sandler | Christopher Raymond | Not Available | Strong Buy |
7/3/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/3/2024 | H.C. Wainwright & Co. | Mitchell S Kapoor | Strong Buy | Strong Buy |
7/3/2024 | Wedbush Securities | Robert Driscoll | Strong Buy | Strong Buy |
4/1/2024 | Cowen & Co. | Tyler Van Buren | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.29 |
ABR (Last week) | 1.29 |
# of Recs in ABR | 7 |
Average Target Price | $27.67 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 83 of 252 |
Current Quarter EPS Est: | -0.40 |
TYRA FAQs
Tyra Biosciences, Inc. (TYRA) currently has an average brokerage recommendation (ABR) of 1.29 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 7 brokerage firms.
The average price target for Tyra Biosciences, Inc. (TYRA) is $27.67. The current on short-term price targets is based on 7 reports.
The forecasts for Tyra Biosciences, Inc. (TYRA) range from a low of $22 to a high of $33. The average price target represents a increase of $25.54 from the last closing price of $22.04.
The current UPSIDE for Tyra Biosciences, Inc. (TYRA) is 25.54%
Based on short-term price targets offered by six analysts, the average price target for Tyra Biosciences, Inc. comes to $27.67. The forecasts range from a low of $22.00 to a high of $33.00. The average price target represents an increase of 28.22% from the last closing price of $21.58.